» Articles » PMID: 34841670

Drug-Dependent Morphological Transitions in Spherical and Worm-Like Polymeric Micelles Define Stability and Pharmacological Performance of Micellar Drugs

Overview
Journal Small
Date 2021 Nov 29
PMID 34841670
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Significant advances in physicochemical properties of polymeric micelles enable optimization of therapeutic drug efficacy, supporting nanomedicine manufacturing and clinical translation. Yet, the effect of micelle morphology on pharmacological efficacy is not adequately addressed. This work addresses this gap by assessing pharmacological efficacy of polymeric micelles with spherical and worm-like morphologies. It is observed that poly(2-oxazoline)-based polymeric micelles can be elongated over time from a spherical structure to worm-like structure, with elongation influenced by several conditions, including the amount and type of drug loaded into the micelles. The role of different morphologies on pharmacological performance of drug loaded micelles against triple-negative breast cancer and pancreatic cancer tumor models is further evaluated. Spherical micelles accumulate rapidly in the tumor tissue while retaining large amounts of drug; worm-like micelles accumulate more slowly and only upon releasing significant amounts of drug. These findings suggest that the dynamic character of the drug-micelle structure and the micelle morphology play a critical role in pharmacological performance, and that spherical micelles are better suited for systemic delivery of anticancer drugs to tumors when drugs are loosely associated with the polymeric micelles.

Citing Articles

Solubilization techniques used for poorly water-soluble drugs.

Xie B, Liu Y, Li X, Yang P, He W Acta Pharm Sin B. 2024; 14(11):4683-4716.

PMID: 39664427 PMC: 11628819. DOI: 10.1016/j.apsb.2024.08.027.


Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.

Yazdimamaghani M, Kolupaev O, Lim C, Hwang D, Laurie S, Perou C Biomaterials. 2024; 312:122750.

PMID: 39126779 PMC: 11401478. DOI: 10.1016/j.biomaterials.2024.122750.


POxload: Machine Learning Estimates Drug Loadings of Polymeric Micelles.

Kehrein J, Bunker A, Luxenhofer R Mol Pharm. 2024; 21(7):3356-3374.

PMID: 38805643 PMC: 11394009. DOI: 10.1021/acs.molpharmaceut.4c00086.


Controlled Release of Drugs from Extracellular Matrix-Derived Peptide-Based Nanovesicles through Tailored Noncovalent Interactions.

Huang H, Hwang J, Anilkumar S, Kiick K Biomacromolecules. 2024; 25(4):2408-2422.

PMID: 38546162 PMC: 11661555. DOI: 10.1021/acs.biomac.3c01361.


Design of Liquid Formulation Based on F127-Loaded Natural Dimeric Flavonoids as a New Perspective Treatment for Leishmaniasis.

da Costa C, Marques E, do Nascimento J, Lima V, Santos-Oliveira R, Figueredo A Pharmaceutics. 2024; 16(2).

PMID: 38399306 PMC: 10891960. DOI: 10.3390/pharmaceutics16020252.


References
1.
Zhou Z, Ma X, Jin E, Tang J, Sui M, Shen Y . Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery. Biomaterials. 2013; 34(22):5722-35. DOI: 10.1016/j.biomaterials.2013.04.012. View

2.
Barua S, Yoo J, Kolhar P, Wakankar A, Gokarn Y, Mitragotri S . Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci U S A. 2013; 110(9):3270-5. PMC: 3587278. DOI: 10.1073/pnas.1216893110. View

3.
He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia M, Stern S . A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials. 2016; 101:296-309. PMC: 5035646. DOI: 10.1016/j.biomaterials.2016.06.002. View

4.
Lim C, Moon J, Sim T, Won W, Lee E, Youn Y . A nano-complex system to overcome antagonistic photo-chemo combination cancer therapy. J Control Release. 2018; 295:164-173. DOI: 10.1016/j.jconrel.2018.12.043. View

5.
Alves V, Hwang D, Muratov E, Sokolsky-Papkov M, Varlamova E, Vinod N . Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs. Sci Adv. 2019; 5(6):eaav9784. PMC: 6594770. DOI: 10.1126/sciadv.aav9784. View